Identification of a functional vitamin D response element in the murine insig-2 promoter and its potential role in the differentiation of 3T3-L1 preadipocytes

Molecular Endocrinology

Volumn 19, Issue 2, 2005, Pages 399-408

  Lee, Seunghee ^a   Lee, Dong Kee ^a   Choi, Eunho ^b   Lee, Jae W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,24,25 TRIHYDROXYCOLECALCIFEROL; INSULIN INDUCED GENE 2 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; STROMA CELL; TRANSCRIPTION INITIATION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BASE SEQUENCE; BONE MARROW CELLS; CALCITRIOL; CELL DIFFERENTIATION; DIMERIZATION; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MEMBRANE PROTEINS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PLASMIDS; PPAR GAMMA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, CALCITRIOL; RESPONSE ELEMENTS; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATION (GENETICS); TRANSFECTION; VITAMIN D;

ANIMALIA; MURINAE;

EID: 13544251468     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0324     Document Type: Article

References (38)

1. Brown MS, Goldstein JL 1999 A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96:11041-11048
2. Goldstein JL, Rawson RB, Brown MS 2002 Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys 397:139-148
3. Amemiya-Kudo M, Shimano H, Yoshikawa T, Yahagi N, Hasty AH, Okazaki H, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Sato R, Kimura S, Ishibashi S, Yamada N 2000 Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J Biol Chem 275:31078-31085
4. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL 1999 Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96:13656-13661
5. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL 2000 Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6:77-86
6. Zhang J, Ou J, Bashmakov Y, Horton JD, Brown MS, Goldstein JL 2001 Insulin inhibits transcription of IRS-2 gene in rat liver through an insulin response element (IRE) that resembles IREs of other insulin-repressed genes. Proc Natl Acad Sci USA 98:3756-3761
7. Hua X, Nohturfft A, Goldstein JL, Brown MS 1996 Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell 87:415-426
8. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS 2002 Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110:489-500
9. Yabe D, Brown MS, Goldstein JL 2002 Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci USA 99:12753-12758
10. Janowski BA 2002 The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP. Proc Natl Acad Sci USA 99:12675-12680
11. Nohturfft A, Yabe D, Goldstein JL, Brown MS, Espenshade PJ 2000 Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell 102:315-323
12. Yabe D, Komuro R, Liang G, Goldstein JL, Brown MS 2003 Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis. Proc Natl Acad Sci USA 100:3155-3160
13. Lee CH, Olson P, Evans RM 2003 Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201-2207
14. Francis GA, Fayard E, Picard F, Auwerx J 2003 Nuclear receptors and the control of metabolism. Annu Rev Physiol 65:261-311
15. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR; Mangelsdorf DJ 2002 Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313-1316
16. Kawada T, Kamei Y, Sugimoto E 1996 The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-dependent transcriptional regulators. Int J Obes Relat Metab Disord 20(Suppl 3):S52-S57
17. Duque G, Macoritto M, Kremer R 2004 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor γ 2 (PPARγ2). Exp Gerontol 39:333-338
18. 3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 139:2622-2628
19. Ishida Y, Taniguchi H, Baba S 1988 Possible involvement of 1 α,25-dihydroxyvitamin D3 in proliferation and differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 151:1122-1127
20. Li J, Takaishi K, Cook W, McCorkle SK, Unger RH 2003 Insig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proc Natl Acad Sci USA 100:9476-9481
21. Takaishi K, Duplomb L, Wang MY, Li J, Unger RH 2004 Hepatic Insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc Natl Acad Sci USA 101:7106-7111
22. Engelking LJ, Kuriyama H, Hammer RE, Horton JD, Brown MS, Goldstein JL, Liang G 2004 Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest 113:1168-1175
23. Kim SW, Park K, Kwak E, Choi E, Lee S, Ham J, Kang H, Kim JM, Hwang SY, Kong YY, Lee K, Lee JW 2003 Activating signal cointegrator 2 required for liver lipid metabolism mediated by liver X receptors in mice. Mol Cell Biol 23:3583-3592
24. Christakos S, Dhawan P, Liu Y, Peng X, Porta A 2003 New insights into the mechanisms of vitamin D action. J Cell Biochem 88:695-705
25. Tontonoz P, Mangelsdorf DJ 2003 Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17:985-993
26. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW 1990 The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem 265:21881-21888
27. Kraichely DM, Collins 3rd JJ, DeLisle RK, MacDonald PN 1999 The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction. J Biol Chem 274: 14352-14358
28. Maestro B, Davila N, Carranza MC, Calle C 2003 Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84:223-230
29. Gascon-Barre M, Demers C, Mirshahi A, Neron S, Zalzal S, Nanci A 2003 The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 37:1034-1042
30. Imagawa M, Tsuchiya T, Nishihara T 1999 Identification of inducible genes at the early stage of adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 254:299-305
31. Kamei Y, Kawada T, Kazuki R, Ono T, Kato S, Sugimoto E 1993 Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 193:948-955
32. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG 2003 Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17:509-511
33. Yamashita T, Eto K, Okazaki Y, Yamashita S, Yamauchi T, Sekine N, Nagai R, Noda M, Kadowaki T 2004 Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a β-cell lipotoxicity model overexpressing sterol regulatory element-binding protein-1c. Endocrinology 145:3566-3577
34. Poitout V, Olson LK, Robertson RP 1996 Insulin-secreting cell lines: classification, characteristics and potential applications. Diabetes Metab 22:7-14
35. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB 1997 Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835
36. Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YK, Kallioniemi OP, Kononen J, Trent JM, Azorsa D, Jhun BH, Cheong JH, Lee YC, Meltzer PS, Lee JW 1999 A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem 274:34283-34293
37. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K 1995 Current protocols in molecular biology. New York: Greene Associates
38. Ledbetter MW, Preiner JK, Louis CF, Mickelson JR 1994 Tissue distribution of ryanodine receptor isoforms and alleles determined by reverse transcription polymerase chain reaction. J Biol Chem 269:31544-31551